The FDA has approved the first Alzheimer’s treatment to slow down cognitive decline. Critics are concerned the new drug doesn’t have enough evidence to guarantee it actually works. Aducanumab is now the first Alzheimer’s drug to be cleared and approved by the United States Food and Drug Administration (FDA). The …
Read More »